SCHEMBL24475480

SCHEMBL24475480

c1cnc2c(c1)ccc1ccc(-c3ccc(-c4ccc5ccc(-c6ccc7ccc(-c8ccc9c%10ccccc%10c%10ccccc%10c9c8)nc7c6)cc5n4)cc3)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 6/20 0.43
KDM4E B2RXH2 5/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
CYP3A4 P08684 3/20 0.41
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
NFKB1 P19838 3/20 0.41
CYP2D6 P10635 2/20 0.41
GMNN O75496 2/20 0.41
TP53 P04637 2/20 0.41
CCR1 P32246 2/20 0.41
THPO P40225 2/20 0.41
CCR5 P51681 2/20 0.41
CCR8 P51685 2/20 0.41
PMP22 Q01453 2/20 0.41
HSP90AA1 P07900 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475679 0.95 NPC1 (0.42) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL23016260 0.91 NPC1 (0.45) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL17899299 0.91 CCR1 (0.47) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL18904452 0.91 CCR1 (0.47) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL18902518 0.91 CCR1 (0.47) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL30960849 0.91 CCR1 (0.47) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL31282562 0.91 CCR1 (0.50) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL17231471 0.91 CCR1 (0.50) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL18886531 0.91 CCR1 (0.50) TOP1KDM4ESMN1; SMN2CYP3A4LMNA
SCHEMBL24454305 0.90 TOP1 (0.42) TOP1KDM4ESMN1; SMN2CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 TOP1 3936/4885KDM4E 3814/4885SMN1; SMN2 4030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.